Current perspectives on camptothecins in cancer treatment.

Por Dancey, J., Eisenhauer, E. A.
Publicado em 1996

Early integration of palliative care into standard oncology care: evidence and overcoming barriers to implementation

Por Kain, D.A., Eisenhauer, E.A.
Publicado no Curr Oncol (2016)

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects

Por Hospers, G A P, Eisenhauer, E A, Vries, E G E de
Publicado em 1999

Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group.

Por Eisenhauer, E. A., Silver, H. K., Venner, P. M., Thirlwell, M. P., Weinerman, B., Coppin, C. M.
Publicado em 1987

Phase ii/iii study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer: ncic ctg ov.21

Por Mackay, H.J., Provencheur, D., Heywood, M., Tu, D., Eisenhauer, E.A., Oza, A.M., Meyer, R.
Publicado em 2011

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours

Por Razak, A R A, Hotte, S J, Siu, L L, Chen, E X, Hirte, H W, Powers, J, Walsh, W, Stayner, L-A, Laughlin, A, Novotny-Diermayr, V, Zhu, J, Eisenhauer, E A
Publicado em 2011

Multigene expression profile testing in breast cancer: is there a role for family physicians?

Por O’Brien, M.A., Carroll, J.C., Manca, D.P., Miedema, B., Groome, P.A., Makuwaza, T., Easley, J., Sopcak, N., Jiang, L., Decker, K., McBride, M.L., Moineddin, R., Permaul, J.A., Heisey, R., Eisenhauer, E.A., Krzyzanowska, M.K., Pruthi, S., Sawka, C., Schneider, N., Sussman, J., Urquhart, R., Versaevel, C., Grunfeld, E.
Publicado no Curr Oncol (2017)